Werfen U.K. Secures 100% of the UK Secondary Donor Testing Market
Werfen U.K. is proud to announce that we have been awarded the contract for NHS Blood and Transplant (NHSBT) Secondary Donor Testing, establishing Werfen as the exclusive provider of secondary donor screening across the United Kingdom.

Following a successful tender process, Werfen is now the Chosen Partner for all four UK blood services:

• NHS Blood and Transplant (NHSBT)
• Scottish National Blood Transfusion Service (SNBTS)
• Welsh Blood Service (WBS)
• Northern Ireland Blood Transfusion Service (NIBTS)

This achievement marks a significant milestone, as 100% of the UK’s Secondary Donor Testing is now performed using Werfen’s Neo Iris analysers. The Neo Iris platform delivers high-throughput, reliable, and accurate results—ensuring the highest standards in donor safety and blood screening.

“We are honoured to be the trusted partner for all U.K. blood services,” said a spokesperson for Werfen U.K. “This partnership reflects our commitment to innovation, quality, and supporting the N.H.S. in delivering safe and effective donor screening.”

With this partnership, Werfen continues to lead in advancing transfusion diagnostics and supporting healthcare systems with cutting-edge solutions.

Report with Confidence. Choose Werfen.